Kristine Swiderek

Company: Mozart Therapeutics

Job title: Chief Scientific Officer

Seminars:

Applying a Novel CD8 Treg Directed Therapeutic Approach to the Clinic 11:00 am

Discussing the significance of regulatory CD8 T cells in autoimmune disease Discussing the therapeutic potential of modulating CD8 Treg for the treatment of autoimmune disease Advancing the CD8 Treg modulator MTX-101 targeting inhibitory KIR as autoimmune checkpoint into the clinic for the treatment of autoimmune diseaseRead more

day: Day Two AM Non-Cell Based Approaches